CClinicalTrials.gg
CompletedNCT01303263Updated Jun 22, 2011

A Brief Intervention to Improve Cost-effective Resource Use Among Medicine Housestaff

An interventional study of Educational Intervention in Graduate Medical Education and Cost-Effectiveness, sponsored by Brigham and Women's Hospital. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2011-06-22.

Sponsored by Brigham and Women's Hospital · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Randomized
Sex
All
01

Study summary

OBJECTIVE: To test a brief intervention designed to improve the cost-effectiveness of care provided by medicine housestaff for hospitalized patients.

HYPOTHESIS: A brief intervention in which medicine residents receive itemized bills for recent patients cared for by them, followed by a discussion on approaches to reducing unnecessary inpatient costs, can result in significant cost reductions without adversely affecting patient outcomes.

Read the detailed description

We designed a brief educational intervention with two primary objectives: 1) to increase awareness among residents about how their decisions impact the costs of inpatient medical care; and 2) to improve the cost-effectiveness of care provided by residents without adversely affecting patient outcomes. We hypothesized that a brief intervention in which residents receive bills for patients they recently cared for, followed by a discussion on approaches to reducing unnecessary inpatient costs, would reduce costs without adversely affecting patient outcomes.

02

Conditions studied

  • Graduate Medical Education
  • Cost-Effectiveness

Keywords

  • efficiency
  • cost-awareness
  • hospitals
  • graduate medical education
03

In context

Lead sponsor

Brigham and Women's Hospital is the lead sponsor of 1,236 studies on the registry; 224 are open to participants now.

Of its 116 completed or terminated interventional studies of FDA-regulated products, 64 (55%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All

Inclusion criteria

  • Internal Medicine Residents on Inpatient Rotations at Brigham \& Women's Hospital

Exclusion criteria

Exclusion Criteria:

  • Having a team member who was in either the control group or intervention group in a prior round of this study.
05

Study design

Phase
Not applicable
Allocation
Randomized
Enrollment
96 participants (actual)

Study arms

  • Other
    Intervention Group

    Residents Randomized to Receive Educational Intervention

    Behavioral: Educational Intervention

  • No intervention
    Control Group

    Residents randomized not to receive a teaching intervention.

Interventions

  • BehavioralEducational Intervention

    45-minute teaching session on healthcare costs, in which each resident reviewed an itemized hospital bill for a patient he/she had cared for, followed by an open-ended discussion about reducing unnecessary costs.

06

What researchers measure

Primary outcomes

  1. Total Cost

    Total hospital cost per admission for 2 weeks following the educational intervention.

    Time frame: 2 weeks following educational intervention

  2. Lab Cost

    Total lab cost per admission for 2 weeks following the educational intervention.

    Time frame: 2 weeks following educational intervention

  3. Pharmacy Cost

    Total pharmacy cost per admission for 2 weeks following the educational intervention.

    Time frame: 2 weeks following educational intervention

  4. Radiology Cost

    Total radiology cost per admission for 2 weeks following the educational intervention.

    Time frame: 2 weeks following educational intervention

Secondary outcomes

  1. length of stay

    Time frame: 2 weeks after educational intervention

  2. admission to an intensive care unit (ICU)

    Time frame: 2 weeks after educational intervention

  3. 30-day readmission

    Time frame: within 30 days after end of study period

  4. 30-day mortality

    Time frame: within 30 days after end of study period

07

Study locations

1 site
  • Brigham & Women's Hospital
    Boston, Massachusetts 02115, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 22, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01303263
Lead sponsor
Brigham and Women's Hospital
Collaborators
Partners Center of Expertise in Quality and Patient Safety
First posted
Feb 24, 2011
Start date
Sep 2009
Primary completion
Dec 2010
Completion
Feb 2011
Last update
Jun 22, 2011

Study contacts

David Bates, MD
principal investigator · Brigham and Women's Hospital
Benjamin D Sommers, MD, PhD
study director · Brigham and Women's Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion